| Specialty Retail Industry | Consumer Discretionary Sector | Mark Alan Hodgson CEO | XSTU Exchange | - ISIN |
| CA Country | 19 Employees | - Last Dividend | 24 Jun 2025 Last Split | - IPO Date |
Willow Biosciences Inc. is a trailblazing biotechnology company focused on the development, production, and commercialization of plant-derived ingredients critical for consumer care, food and beverage, and pharmaceutical industries. Established in 2019 and based in Calgary, Canada, the company leverages the latest advancements in biotechnology to innovate in the field of natural ingredient synthesis. Willow Biosciences operates primarily within the United States but has fostered global partnerships, such as with SUANFARMA for the development of anti-infective API through precision fermentation, and with Laurus Labs for the manufacturing of active pharmaceutical ingredients. These collaborations underscore Willow Biosciences’ commitment to cutting-edge research and its capabilities in bringing high-quality, plant-derived ingredients to market.
Willow Biosciences specializes in creating high-purity, plant-derived ingredients for use in various consumer care products. Leveraging biotechnological innovations, the company offers environmentally sustainable and ethically produced alternatives to traditional chemically synthesized ingredients.
Understanding the growing consumer demand for natural and healthy ingredients, Willow Biosciences develops and supplies plant-derived ingredients that can be incorporated into food and beverage products. These ingredients are designed to enhance nutritional value without compromising taste or quality.
Through its expertise in biotechnology, Willow Biosciences produces active pharmaceutical ingredients (APIs) with a focus on precision, quality, and scalability. The company's collaboration with Laurus Labs enhances its capability to supply these critical components for pharmaceutical manufacturing, including APIs with anti-infective properties developed through a partnership with SUANFARMA.